Underpinning the UK National COPD Strategy

Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort
Rupert C M Jones, MD, Prof David Price, MD; Dermot Ryan, MD; Erika J Sims, PhD;
Julie von Ziegenweidt; Laurence Mascarenhas, MSc; Anne Burden, MSc; David M G Halpin, DPhil; Robert Winter, MD; Prof Sue Hill, PhD; Matt Kearney, MRCGP; Kevin Holton; Anne Moger, MSc; Daryl Freeman, MRCGP; Alison Chisholm, MSc; Prof Eric D Bateman, PhD, on behalf of The Respiratory Effectiveness Group
Lancet Respiratory Medicine: Volume 2, No. 4, p267–276, April 2014

Active comorbidities at the time of COPD diagnosis

Lead Investigator:

David Price, Primary Care Respiratory Society UK, Professor of Primary Care Respiratory Medicine, University of Aberdeen

Research Team: 

D Price*, R Jones, D Halpin, R Winter, SL Hill, E Bateman, D Freeman, M Kearney, K Holton, A Moger, A Burden, J von Ziegenweidt, L Mascarenhas, A Chisholm, D Ryan

Short description:

  • Rationale: Comorbidities can potentiate the morbidity of COPD, and vice versa. Patients with COPD often die as a result of a comorbidities.
  • Objectives:
    • To evaluate the prevalence of comorbidities at COPD diagnosis in real-world patients over a 10-yr period
    • To identify trends in sequential diagnosis of COPD and comorbidities
    • To identify extent of comorbidities at time of COPD and related diagnostic trends
    • To identify potential holistic management recommendations .

Status: 

  • Analysis complete
  • Oral presentation at ERS 2011 (Amsterdam). Presented by Dr Dermot Ryan, Loughborough.
  • Manuscript submitted to BMJ for consideration

Links (these links will become activated as the various study outputs become available)

Missed diagnostic opportunities in COPD

Lead Investigator:

David Price, Primary Care Respiratory Society UK, Professor of Primary Care Respiratory Medicine, University of Aberdeen

Research Team: 

D Price*, R Jones, D Halpin, R Winter, SL Hill, E Bateman, D Freeman, M Kearney, K Holton, A Moger, A Burden, J von Ziegenweidt, L Mascarenhas, A Chisholm, D Ryan

Short description:

  • Rationale: Early diagnosis and intervention in the management of symptomatic COPD may reduce the impact of the disease in terms of (reduced) exacerbations, slower disease progression and lung function decline and result in a reduced economic burden on healthcare systems.
  • Objectives: To use large primary care clinical databases to:
    • Characterise the current COPD population
    • Ascertain the stage at presentation
    • Evaluate the consultation pattern prior to diagnosis
    • Identify flags to aid in earlier diagnosis

Status: 

  • Analysis complete
  • Oral presentation at ERS 2011 (Amsterdam). Presented by Dr Rupert Jones, Plymouth.
  • Manuscript submitted to BMJ for consideration

Links (these links will become activated as the various study outputs become available)